NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo shows promise against Slow-Growing blood cancer
Disease control OngoingThis study tests whether combining copanlisib and rituximab can slow or stop follicular lymphoma, a type of blood cancer, in people who haven't had treatment yet. About 33 participants will receive the drugs through an IV over several months. The goal is to see how many achieve a…
Matched conditions: NHL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
Immunotherapy after chemo shows promise for aggressive lymphoma
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab after standard chemotherapy can help prevent cancer from returning in people with high-risk diffuse large B-cell lymphoma. About 109 adults aged 18-75 who achieved complete remission after initial treatment will …
Matched conditions: NHL
Phase: PHASE2 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated May 22, 2026 13:50 UTC